1. Home
  2. Live Updates
  3. Metastatic cancer

Live Breaking News & Updates on Metastatic cancer

Stay informed with the latest breaking news from Metastatic cancer on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Metastatic cancer and stay connected to the pulse of your community

Sonali Bendre opens up about her initial response to cancer diagnosis: 'Why Me?' |

Sonali Bendre reflected on her cancer journey, shifting from 'Why me?' to 'Why not me?' Diagnosed with stage four cancer, treated in New York City, no

New-york , United-states , Bombay , Maharashtra , India , Shriya-pilgaonkar , Jaideep-ahlawat , Sonali-bendre , New-york-city , Cancer-survivors-day , Broken-news-

A view from Wrexham's Member of Parliament

A view from Wrexham's Member of Parliament
wrexham.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wrexham.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Berwyn , Powys , Wrexham , Wrexham-maelor , Sarah-atherton , Dewr-lifehouse , Health-board , Betsi-cadwaladr-university-health-board , Wrexham-member-of-parliament , Wrexham-clwyd-south-members-of-parliament , Employment-development-coordinator

Petition to save Wrexham's Metastatic Cancer Nurse

By Sarah Atherton

United-kingdom , Wrexham , Ukraine , Russia , High-wycombe , Buckinghamshire , Ukrainian , Iryna-nykorak , Defence-committee , Armed-forces-from-recruitment-to-civilian-life , National-air-space-operations , Prime-minister

Wrexham: Sarah Atherton MP concerned about hospital post

Wrexham: Sarah Atherton MP concerned about hospital post
leaderlive.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leaderlive.co.uk Daily Mail and Mail on Sunday newspapers.

Wrexham , United-kingdom , Betsi-cadwaladr-university-health-board , Health-board , Metastatic-cancer-nurse , Welsh-government , United-kingdom-government , Spring-budget , Social-care , Save-wrexham , Metastatic-cancer

McKesson's Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services

McKesson has received approval from the CMS to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry.

United-states , American , Christine-davis , Erin-crum , Infusion-center , Us-oncology-network , Screening-for-social-drivers-of-health , Centers-for-medicare-medicaid-services , National-comprehensive-cancer-network , American-society-of-clinical-oncology , Mckesson , Medicaid-services

Elacestrant: Adverse Effects and Their Management, and Impact of Treatment on Quality of Life

Experts discuss the impact of elacestrant on patient well-being, including potential cardiovascular and gastrointestinal toxicities, quality of life, and patient feedback regarding access to treatment.

William-gradishar , Gregory-vidal , Rena-callahan , Mabel-mardones , Peer-exchange , European-society-for-medical-oncology-congress , Medical-oncology-congress , Oral-serd , Mbc , Metastatic-breast-cancer , Serd , Therapeutic-advances

Elacestrant: Treatment Considerations, Including Dosing and Compliance

Experts explore treatment considerations when treating patients with metastatic breast cancer with elacestrant, including dosing, patient selection, adherence, and treatment duration. Participants also discuss dose modifications, adherence concerns, and how they determine treatment failure.

William-gradishar , Mabel-mardones , Rena-callahan , Gregory-vidal , Peer-exchange , Oral-serd , Mbc , Metastatic-breast-cancer , Serd , Therapeutic-advances , Panel-discussion , Er-positive

Elacestrant in Later-Line Treatment of ER+/HER2– Metastatic Breast Cancer

Experts delve into practical aspects of using elacestrant in later-line treatment of patients with estrogen receptor–positive (ER+)/HER2-negative (HER2–) metastatic breast cancer, including testing for ESR1 mutations, evaluating efficacy, and monitoring for toxicity.

Rena-callahan , William-gradishar , Mabel-mardones , Gregory-vidal , Peer-exchange , Oral-serd , Mbc , Metastatic-breast-cancer , Serd , Therapeutic-advances , Panel-discussion , Er-positive

ESR1 Mutation Testing and Precision Medicine in Patients With ER+/HER2- Metastatic Breast Cancer

Experts discuss the necessity of ESR1 mutation testing when considering treatment with elacestrant in patients with estrogen receptor–positive (ER+)/HER2-negative (HER2–) metastatic breast cancer and discuss unmet needs in this patient population. They also describe options for mutation and resistance marker testing to guide treatment selection.

William-gradishar , Rena-callahan , Mabel-mardones , Gregory-vidal , Peer-exchange , Oral-serd , Mbc , Metastatic-breast-cancer , Serd , Therapeutic-advances , Panel-discussion , Er-positive

Elacestrant Usage in ER+/HER2- Metastatic Breast Cancer: Clinical Guidelines and Patient Profiles

Experts discuss how they determine whether a patient with metastatic breast cancer is a candidate for treatment with elacestrant based on FDA approved indication, NCCN guidelines, and the results of ESR1 mutation and resistance marker testing. Participants also discuss how they determine treatment failure or resistance.

Breast-cancer , Clinical-guidelines , Oral-serd , Mbc , Metastatic-breast-cancer , Serd , Therapeutic-advances , Panel-discussion , Er-positive , Her2-negative , Selective-estrogen-receptor-degrader